Posts

Showing posts with the label Clostridium Diagnostics Market

Clostridium Diagnostics Market - Forecast 2022-2027

Clostridium Diagnostics Market size is estimated to reach $1.9 billion by 2027, growing at a CAGR of 7.3% during the forecast period 2022-2027. Clostridium is a gram-positive bacterium that can be found in a variety of forms. Disease-causing form of Clostridium bacteria which causes Clostridium difficile infection (CDI), a gastrointestinal ailment, frequently considered synonymous with antibiotic-associated diarrhea (AAD), is Clostridioides difficile. Clostridium perfringens, Clostridium botulinum, Clostridium tetani and Clostridium sordellii cause gas gangrene, muscle necrosis, botulism, tetanus, pneumonia, endocarditis, arthritis and peritonitis. Frequent use of antibiotics leads to rapid multiplication of Clostridium difficile bacteria, owing to the absence of good microflora attributed to the effect of frequent consumption of antibiotics. However, antibiotics like benzylpenicillin, sulfonamides, tetracyclines, metronidazole, vancomycin and carbapenems are used to cure the infectio...